3-phenyllactic acid has been researched along with MS (Multiple Sclerosis) in 1 studies
3-phenyllactic acid: alpha-hydroxy analog of phenylalanine; RN given refers to cpd without isomeric designation
3-phenyllactic acid : A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oezguen, N | 1 |
| Yılmaz, V | 1 |
| Horvath, TD | 1 |
| Akbayir, E | 1 |
| Haidacher, SJ | 1 |
| Hoch, KM | 1 |
| Thapa, S | 1 |
| Palacio, J | 1 |
| Türkoğlu, R | 1 |
| Kürtüncü, M | 1 |
| Engevik, MA | 1 |
| Versalovic, J | 1 |
| Haag, AM | 1 |
| Tüzün, E | 1 |
1 other study available for 3-phenyllactic acid and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios.
Topics: B-Lymphocyte Subsets; Fingolimod Hydrochloride; Humans; Interleukin-4; Multiple Sclerosis | 2022 |